Digital Journal reports CBLPath, Inc., a pathology services provider, and Agendia, a molecular diagnostics company, announced their collaboration to provide molecular diagnostics testing for breast cancer patients.
via Rye Brook Newswire http://ift.tt/1rtEzXR
via Rye Brook Newswire http://ift.tt/1rtEzXR
No comments:
Post a Comment